Are surface markers of cancer stem cells reliable factors for cancer treatment follow-up?

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Comparative Clinical Pathology

• Publication date

  2017-06-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s00580-017-2504-5
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• BRAF Mutation and its Effects on Radioiodine Uptake in Patients with Anaplastic Thyroid Carcinoma

  2017cited by this paper
• Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.

  2016cited by this paper
• BRAF Mutation and its effects on Radioiodine Uptake in Patients with Anaplastic Thyroid Cancer

  2016cited by this paper
• Association Between Expression of Cancer Stem Cell Markers and Poor Differentiation of Hepatocellular Carcinoma

  2015cited by this paper
• The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells?

  2015cited by this paper
• Cancer stem cells in glioblastoma

  2015cited by this paper
• The cancer stem cell gamble.

  2015cited by this paper
• Relationship between PI3K Mutation and Sodium-Iodide Symporter in Anaplastic Thyroid Carcinoma

  2015cited by this paper
• Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer

  2014cited by this paper
• An agent-based model of cancer stem cell initiated avascular tumour growth and metastasis: the effect of seeding frequency and location

  2014cited by this paper
• Isolation and Characterization of Cancer Stem Cells from High-Grade Serous Ovarian Carcinomas

  2014cited by this paper
• Enrichment of Prostate Cancer Stem-Like Cells from Human Prostate Cancer Cell Lines by Culture in Serum-Free Medium and Chemoradiotherapy

  2013cited by this paper
• RNA aptamers targeting cancer stem cell marker CD133.

  2013cited by this paper
• An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells

  2013cited by this paper
• Physiologic Oxygen Concentration Enhances the Stem-Like Properties of CD133+ Human Glioblastoma Cells In vitro

  2009cited by this paper
• CD44 and EpCAM: cancer-initiating cell markers.

  2008cited by this paper
• The biology of cancer stem cells.

  2007cited by this paper
• AC133-2, a Novel Isoform of Human AC133 Stem Cell Antigen* 210

  2002cited by this paper

• Targeting the BRAF Signaling Pathway in CD133pos Cancer Stem Cells of Anaplastic Thyroid Carcinoma

  2019cites this paper
• Effects of a Phosphoinositide-3-Kinase Inhibitor on Anaplastic Thyroid Cancer Stem Cells

  2017cites this paper